Literature DB >> 34200086

Vertigo in Patients with Degenerative Cervical Myelopathy.

Zdenek Kadanka1,2, Zdenek Kadanka1,2, Rene Jura1,2, Josef Bednarik1,2.   

Abstract

(1) Background: Cervical vertigo (CV) represents a controversial entity, with a prevalence ranging from reported high frequency to negation of CV existence. (2)
Objectives: To assess the prevalence and cause of vertigo in patients with a manifest form of severe cervical spondylosis-degenerative cervical myelopathy (DCM) with special focus on CV. (3)
Methods: The study included 38 DCM patients. The presence and character of vertigo were explored with a dedicated questionnaire. The cervical torsion test was used to verify the role of neck proprioceptors, and ultrasound examinations of vertebral arteries to assess the role of arteriosclerotic stenotic changes as hypothetical mechanisms of CV. All patients with vertigo underwent a detailed diagnostic work-up to investigate the cause of vertigo. (4)
Results: Symptoms of vertigo were described by 18 patients (47%). Causes of vertigo included: orthostatic dizziness in eight (22%), hypertension in five (14%), benign paroxysmal positional vertigo in four (11%) and psychogenic dizziness in one patient (3%). No patient responded positively to the cervical torsion test or showed significant stenosis of vertebral arteries. (5) Conclusions: Despite the high prevalence of vertigo in patients with DCM, the aetiology in all cases could be attributed to causes outside cervical spine and related nerve structures, thus confirming the assumption that CV is over-diagnosed.

Entities:  

Keywords:  cervical dizziness; cervical torsion test; cervical vertigo; degenerative cervical myelopathy; degenerative cervical spinal cord compression

Year:  2021        PMID: 34200086     DOI: 10.3390/jcm10112496

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  1 in total

1.  Degenerative Cervical Myelopathy and Spinal Cord Injury: Introduction to the Special Issue.

Authors:  Khadija Soufi; Aria Nouri; Allan R Martin
Journal:  J Clin Med       Date:  2022-07-22       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.